Barely Significant

Excerpts

514,629 sentences

a positive trendp < 0.010.2× alphagold
A negative and significant mean latent trajectory was evident for LS (unstandardized μ LS –S = −0.11 [−0.16 −0.06, SE = 0.03, p < 0.001), and PA (unstandardized μ PA–S = −0.13 [−0.18 −0.08], SE = 0.03, p < 0.01), and a positive trend for NA (unstandardized μ NA–S = 0.074 [0.03.22], SE = 0.03, p < 0.01).
extremely significantP = 0.010.2× alphaqualified
Cd concentration measurements, with pYES2.0 as the control, revealed that the Cd content of SaGLIP8 -overexpressive yeast was significantly greater than that of pYES2.0, and the difference between the two was extremely significant ( P = 0.01) ( Fig. 8B ).
highly significantP <0.010.2× alphaqualifiedgold
The comparisons between groups within months were made using least significant difference (LSD) test with the differences considered significant at P <0.05 and highly significant at P <0.01 and P <0.001 levels.
highly significantP <0.010.2× alphaqualifiedgold
In personal interviews conducted by a gynecologist, after already one month into Treatment A, a great majority of women receiving both Maca-GO and Placebo treatment (19 of 20) observed highly significant ( P <0.01) reduction in feeling discomfort typically observed in the early perimenopausal stage as assessed by answers given to the questions according to Kupperman’s Menopausal Index (KMI) and expressed by the total point score of this Index (Figure 2 ).
highly significantP < 0.010.2× alphaqualifiedgold
6 A, Ligilactobacillus showed a highly significant positive correlation with phloretin, Neocarthamin, Maesopsin 6-glucoside, Humilixanthin, and most of the metabolites ( P < 0.01), and similar results were found also in Anaeroplasma ( P < 0.05).
highly significantp < 0.010.2× alphaqualifiedgold
As expected, chi-square test showed that at all times of observation, the patients treated with the considered medications or hospitalized for the above-mentioned concomitant diseases were markedly more represented in MG and in non-MG population (highly significant, p < 0.01). 3.4 Patient costs The mean total annual costs per patient were €3771 for the first year, €2827 for the second and 2555 for the third year of follow-up, mainly driven by hospitalizations (€2198 for the first, €1316 for the second and €1054 for the third year) and drugs (€1,148, €1122 and €1122).
extremely significantp < 0.010.2× alphaqualified
As shown in Figure 9 b, compared with the control group, YL-1 polysaccharide (>12.5 μg/mL) increased IL-6 expression of RAW264.7 cells, and the difference was extremely significant compared with the control group ( p < 0.01) in the concentration range of (5–200 μg/mL).